Moreover, compound 1 caused growth arrest, and induced cell senescence of breast cancer cells, rendering it as a potential lead compound for the development of more efficacious drug candidates against KDM5A-overexpressing breast cancer. This evidence concerns the gene KDM5A and breast carcinoma.